INTRODUCTION
wEf11 is a temperate bacteriophage that was induced from a lysogenic root canal isolate of Enterococcus faecalis (Stevens et al., 2009) . It is a member of the family Siphoviridae, with a long (130 nm) non-contractile tail and a small (41 nm diameter) spherical/icosohedral head. The phage produces small, turbid plaques in lawns of E. faecalis JH2-2. The wEf11 DNA has been sequenced and annotated, disclosing a genome of 42 822 bp encoding 65 ORFs (Stevens et al., 2011) . Furthermore, our previous studies disclosed that the wEf11 DNA restriction pattern produced with certain restriction enzymes, such as NsiI, produced several fragments in submolar amounts (Stevens et al. 2009 ). This would be expected to occur in the case of a circularly permuted genome due to headful packaging of a concatemeric phage DNA during viral maturation.
The wEf11 host species, E. faecalis, and closely related species, such as Enterococcus faecium, have emerged as significant human pathogens, being major aetiological agents of infectious endocarditis, nosocomial infections, burn infections, urinary tract infections, meningitis and surgical wound infections (Lewis & Zervos, 1990; Moellering, 1992; Megran, 1992; Emori & Gaynes, 1993; Jett et al., 1994; Edgeworth et al., 1999; Richards et al., 2000; National Nosocomial Infections Surveillance System, 2004; Biedenbach et al., 2004; Linden, 2007) . In terms of oral disease, E. faecalis is the most commonly isolated species from infected root canals of teeth that fail to heal following root canal therapy (Sundqvist et al., 1998; Peciuliene et al., 2000; Pinheiro et al., 2003 Complicating management of these infections is the development of resistance among many enterococcal strains against many of the available, previously effective antibiotics, including vancomycin (Havard et al., 1959; Murray & Mederski-Samaroj, 1983; Uttley et al., 1988; Grayson et al., 1991; Bonten et al., 2001; Tenover & McDonald, 2005) . Although a modest number of new antibiotics, such as linezolid and daptomycin, have been developed to provide treatment alternatives in cases of infection by organisms that are resistant to all previously available antibiotics, there have been numerous reports of resistance by E. faecalis and E. faecium strains to these antibiotics as well (Eliopoulos et al., 1998; Prystowsky et al., 2001; Gonzales et al., 2001; Herrero et al., 2002; Johnson et al., 2004; Munoz-Price et al., 2005; Kanafani et al., 2007; Hidron et al., 2008; Marshall et al., 2009; Kelesidis et al., 2011; Ross et al., 2011; Ntokou et al., 2012) . Therefore, alternative approaches to manage these infections should be explored.
We have been exploring the possibility of engineering variants of phage wEf11 that might be effective in controlling these infections. wEf11 possesses several characteristics making it a favourable candidate virus to be used in phage therapy: there are no toxin-related genes detected in the wEf11 genome, and it encodes several (4-6) genes encoding proteins with lysis-associated functions (Stevens et al., 2011) . However, as a temperate virus that is difficult to propagate, wild-type wEf11 would certainly not be suitable as a potential therapeutic agent. It would not be expected to infect strains of E. faecalis lysogens due to repressor-mediated superinfection immunity, nor would it be expected to be highly lytic by virtue of its ability to enter into a lysogenic life cycle. Consequently, in its wild-type state, it would have an unacceptably limited host range. Therefore, we sought to determine whether appropriate genetic modifications of wEf11 would result in a virulent, highly lytic variant that was insensitive to repression and incapable of lysogeny. These studies shed light on some of the regulatory mechanisms that function in controlling the life cycle of this bacterial virus, and generated a variant phage that had a notably broader host range. Here, we present the identification of the phage virulence determinants, and the development of a virulent version of the temperate E. faecalis bacteriophage wEf11.
METHODS
Bacterial strains and growth conditions. TUSoD11 is a lysogenic E. faecalis strain, harbouring a wEf11 prophage, which was previously isolated from an infected root canal (Stevens et al., 2009) . Following curing, the non-lysogenic variant of this strain was designated E. faecalis TUSoD11 (DwEf11). JH2-2 is a Fus r , Rif r mutant of a clinical E. faecalis isolate (Jacob & Hobbs, 1974 ) that was generously provided to us by Dr Nathan Shankar. In the course of this study, it was found that this strain harboured a wFL1C-type prophage element (Yasmin et al., 2010) , indicating that this strain was a lysogen with a defective prophage. Other E. faecalis strains used in this study are listed in Table 1 . All strains were grown in brain-heart infusion (BHI) broth (or on BHI agar, with appropriate antibiotics). Escherichia coli One Shot Mach-T1 (Invitrogen) was used in cloning plasmids as described below. Cells were grown in Luria-Bertani (LB) medium supplemented with the appropriate antibiotics. Additional bacterial species used as negative controls in PCR experiments are also listed in Table 1 .
Construction of recombinant plasmids. The nisin promoter (P nisA ) cassette containing an erythromycin selection marker (erm) was PCR-amplified using the AccuPrime DNA Taq Polymerase High Fidelity kit (Invitrogen) with primer set PNISaF/PNISR (see Table 2 for primer specifications) from plasmid pMSP3535 (Bryan et al., 2000) , a kind gift from Dr B. Buttaro. PCRs were performed in 30 ml reaction mixtures containing 2 ml template DNA, 2 ml (20 pmol) forward primer, 2 ml (20 pmol) reverse primer, 21.5 ml distilled H 2 O, 2 ml buffer (provided by the manufacturer) and 0.5 ml AccuPrime DNA Taq polymerase. The PCR programme used was: 95 uC for 2 min, followed by 35 cycles of (i) 95 uC for 45 s, (ii) 55 uC for 45 s and (iii) 72 uC for 2 min. This was followed by an additional 5 min extension at 72 uC. Following PCR, the amplicons were detected by agarose gel electrophoresis and ethidium bromide staining. The amplicons generated by this procedure were cloned into pCR8/GW/ TOPO vector (Invitrogen) to create pErm-PnisA (Fig. S1 , available in Microbiology Online). The two-component nisin sensor system (nisR/ nisK) which controls the activation of P nisA by nisin was also amplified from pMSP3535 by PCR, using primer set RKnpF/RKaxR, and cloned into pCR8/GW/TOPO to create pRK. The P nisA fragment plus the erythromycin selection marker was digested from pErmPnisA with AatII and SphI, and inserted into pRK to create pRK-ErmPnisA. A fragment (pre31) of 1088 bp from nucleotide coordinates 24 585 to 25 672 of wEf11 (upstream of ORF31, the first gene of the putative lysogeny module) and a fragment (post36) of 1090 bp from 28 588 to 29 577 of wEf11 (immediately upstream of the putative cro gene, ORF37) were PCR-amplified using primer sets EF31UF/ EF31UR and EF37DF/EF37DR, respectively, and cloned into pCR8/ GW/TOPO to create pPre31 and pPost36. The post36 fragment was cut out from the pPost 36 with BamHI and SphI and inserted into pRK-Erm-PnisA, to create pPost36-RK-PnisA. The pPre31 was first digested with EcoRI and blunt-ended with the Klenow fragment of DNA polymerase I (Promega), then digested with PstI. Following this, the digested pre31 fragment was cloned into pPost36-RK-PnisA to create the allelic exchange plasmid pD31-36 P nisA .
Isolation of spontaneous phage wEf11/wFL1C-like recombinant [wEf11(D61-1, wFL1C40-44)] and the creation of a lysogen harbouring the recombinant prophage. An exponential phase BHI broth culture of E. faecalis JH2-2 was inoculated with phage wEf11. After incubation at 37 uC for 1 h, the culture was centrifuged (17 000 g for 3 min) and the supernatant was filtered (0.45 mm) before being plaque-assayed. After overnight incubation at 37 uC, the plates were examined, and several large, extensively spreading plaques were noted among a background of small, turbid plaques. These large plaques were picked, and the virus in these large plaques was cloned by successive plaque purifications. The genomic DNA from the cloned virus was sequenced by Sanger di-deoxy sequencing reactions as described previously (Stevens et al., 2011) .
To create a lysogen harbouring a wEf11(D61-1, wFL1C40-44) prophage, JH2-2 cells from surviving colonies in the centre of the large plaques produced by this virus were cloned and screened for the presence of the recombinant phage genome. This was done by PCR using primers (EF60F/FL1A35R) that recognized wEf11 ORF 60 at the 59 end and wFL1C ORF 40 at the 39 end (see Table 2 for primer specifications). The lysogen harbouring this recombinant prophage was designated E. faecalis JH2-2[wEf11(D61-1, wFL1C40-44); (Fig. 1 ). In addition, virus spontaneously released from this lysogen was detected by plaque assay, and also confirmed to be recombinant by PCR analysis.
Deletion of the lysogeny module and replacement of cro promoter with P nisA by allelic exchange. Cells of E. faecalis lysogen JH2-2[wEf11(D61-1, wFL1C40-44)] were made competent using the procedures described by Shepard & Gilmore (1995) . Briefly, the cells were grown in SGM17 medium (37.25 g M17 l 21 , 0.5 M sucrose and 8 % glycine) for 48 h at 37 uC. The cells were then harvested by centrifugation, washed twice with EB buffer (0.5 M sucrose and 10 % glycerol), and finally resuspended in EB buffer. Plasmid pD31-36 P nisA was linearized with XhoI and then electroporated into the competent JH2-2 lysogens using the Bio-Rad MicroPulser System. Following electroporation, 1 ml SGM17MC medium (SGM17 plus 10 mM MgCl 2 and 10 mM CaCl 2 ) was added to the electroporation cuvette, which was then incubated for 2 h. Transformants were selected on BHI agar containing erythromycin (30 mg ml 21 ). Presumptive transformant colonies were screened for deletion of the lysogeny module genes (wEf11 ORFs 31-36) and replacement of P cro by P nisA by PCR using primers EF31UUF/RK5R, PNIS3F/37DDR, EF31MF/EF31MR and EF36MF/EF36MR. In addition, control of lytic functions in the prophage by P nisA was demonstrated by measuring phage induction in the presence or absence of nisin (40 ng ml 21 ). The phage recovered from the induced lysogens lacking ORFs 31-36 and P cro , but containing the P nisA promoter, was designated wEf11(vir) PnisA .
Screening for the presence of wEf11 prophages in E. faecalis strains. Primers specific to wEf11 were designed from wEf11 ORF 43 (GenBank accession number GQ452243). This sequence (ORF 43) of the wEf11 genome was chosen as searches of all available databases failed to disclose any homologous sequences to this gene. The forward (wEf11F) and reverse (wEf11R) primers for amplification of a 165 bp amplicon of this gene are specified in Table 2 . Template DNA was prepared as follows: 10 ml broth cultures of each strain to be screened were pelleted by centrifugation, washed in 4 ml wash solution [20 mM Tris/HCl (pH 8.5), 0.85 % NaCl], resuspended in 2 ml lysis buffer [1 % Triton X-100, 20 mM Tris/HCl (pH 8.5), 2 mM EDTA], and heated to 95-100 uC for 10 min. The suspension was then centrifuged and the supernatants were collected and frozen at 280 uC until used in PCR assays (Goncharoff et al., 1993) . Extracts from E. faecalis TUSoD11 (lysogenic for wEf11) were used as positive controls, and extracts from E. faecalis JH2-2 (non-lysogenic for wEf11) and Oral isolates 6, 8 GS1, GS2, GS3, GS4, GS5, GS6, GS7, GS8, GS9, GS10, GS12, GS13, GS14, GS15, GS16, GS17, GS18, GS19, GS21, GS22, GS23, GS24, GS25, GS26, GS27, GS28, GS29, GS30, GS31, GS32, GS33 Virulence-associated alterations in phage wEf11 genome numerous unrelated species (see Table 1 ) were used as negative controls. Reaction mixtures (total 40 ml) for PCR contained 5 ml template DNA, 5 ml (50 pmol) forward primer, 5 ml (50 pmol) reverse primer, 5 ml distilled H 2 O and 20 ml 26 Go Taq green PCR master mix (Promega). The PCR programme used was 97 uC for 1 min, followed by 26 cycles of (i) 97 uC for 1 min, (ii) 50 uC for 45 s and (iii) 72 uC for 1 min. This was followed by an additional 4 min at 72 uC. Following PCR, amplification products were detected by agarose (2 %) gel electrophoresis and ethidium bromide staining.
Preparation of cured E. faecalis TUSoD11. Cells of E. faecalis TUSoD11 were made competent for electroporation as described above. After electroporation with the allelic exchange vector pD31-36 PnisA, erythromycin-resistant colonies were screened for homologous recombination-mediated deletion of the lysogeny module genes (ORFs 31-36) in the genome of E. faecalis TUSoD11. Strains exhibiting deletion of ORFs 31-36 were further tested by PCR for the presence of wEf11 genes outside of the lysogeny module. In addition to clones containing wEf11 genes other than ORFs 31-36, a few rare clones were identified that lacked any of the wEf11 genes. Such clones could not be induced, but could now be infected by phage wEf11. These cured clones were designated E. faecalis TUSoD11(DwEf11).
Testing adsorption of wEf11 and wEf11(D61-1, wFL1C40-44) to lysogenic and non-lysogenic E. faecalis strains. E. faecalis strains JH2-2, TUSoD11 and the cured strain, TUSoD11 (DwEf11), were grown in BHI medium to exponential phase. Then, 100 ml of wEf11 or wEf11(D61-1, wFL1C40-44) preparations were added to 1 ml E. faecalis strains. After incubation at 37 uC for 10 min the mixtures were centrifuged at 17 000 g for 3 min, the supernatants were filtered through 0.45 mm filters and filtrates containing any unadsorbed phage were plaque-assayed, using JH2-2 indicator cells, to determine residual phage titres.
One-step growth curve. Cells of an exponential phase BHI broth culture (2 ml) of E. faecalis JH2-2 were collected by centrifugation, resuspended in 1 ml BHI broth, and inoculated with 100 ml of a stock culture of either phage wEf11, wEf11(D61-1, wFL1C40-44) or wEf11 (vir) PnisA . After incubation for 30 min to allow phage adsorption, the cells were recovered by centrifugation, washed three times in BHI broth and finally resuspended in 10 ml BHI broth. Aliquots (500 ml) of the suspension were made, and each was incubated at 37 uC. At various time points, an aliquot was centrifuged to remove the cells, and the supernatant was plaqueassayed, using fresh JH2-2 indicator cells, for phage titre.
Host range determination for wEf11, wEf11(D61-1, wFL1C40-44) and wEf11(vir) PnisA . Plaque assays and spot tests were conducted with wild-type phage wEf11 and recombinant phages wEf11(D61-1, wFL1C40-44) and wEf11 (vir) PnisA using the panel of 67 E. faecalis strains listed in Table 1 as indicators. The E. faecalis panel included both lysogenic and non-lysogenic strains. Lytic infection by each phage was detected by plaque assay with each E. faecalis indicator strain.
RESULTS
Isolation of spontaneous wEf11/wFL1C recombinant Following repeated propagation and plaque assay of phage wEf11 on host strain E. faecalis JH2-2, it became evident that variants of the wild-type virus were being generated. Whereas wild-type wEf11 produced small, turbid plaques in lawns of JH2-2, approximately 0.02 % of the plaques appeared as large, extensively spreading, somewhat clearer zones of lysis (Fig. 2) . Interestingly, incubation of plaque assays of clones obtained by plaque purification of the virus producing these larger plaques resulted in continued expansion of the plaques to the extent that virtually the entire JH2-2 lawn was lysed (Fig. 2) . In contrast, wild-type plaques typically disappeared after extended incubation, presumably due to growth of surviving lysogens within the plaques (Fig. 2) . Agarose gel electrophoresis analysis of the NdeI restriction fragments of the DNA from the virus producing these large plaques revealed that it was missing one of the fragments (fragment 6, 2.79 kbp) that was present in the NdeI DNA digestion of the original wEf11 isolate (Fig. S2 ). In addition, it was also noted that another of the NdeI fragments (fragment 2, approx. 9.4 kbp) from the DNA of the virus producing the large plaques had increased in size (compared with NdeI fragment 2 from the original wEf11 DNA) by an amount approximately equal to the size of the missing NdeI fragment 6 (Fig. S2 ). Close inspection of the wEf11 NdeI restriction map (Fig. S3 ) and the wEf11 NdeI restriction digest summary (Table S1 ) revealed that NdeI fragment 6 was composed of the two extreme ends of the genome (fragment coordinates 0-1036 plus 41 068-42 822), and that in a circularly permuted genome, this fragment is immediately adjacent to NdeI fragment 2 (coordinates 33 692-41 068; Fig. S3 ). Sequencing this region of the genome disclosed that ORFs 60-65 and 1 (coordinates 39 671-42 822 and 1-336) were replaced by ORFs 40-44 (coordinates 14 600-17 336) of E. faecalis phage wFL1C (Fig. 1) . Furthermore, the NdeI restriction site at coordinate 41 068, which divides NdeI fragment 2 from Ndel fragment 6 in the wEf11 DNA, is absent in the wFL1C DNA and consequently in the DNA of the recombinant virus (Fig. 1) . PCR, restriction fragment analysis and partial sequencing of the recombinant DNA failed to detect any other modifications to the wEf11 genome. Consequently, this wEf11/wFL1C recombinant was designated phage wEf11(D61-1, wFL1C40-44). Because the JH2-2 genome was the only possible source of the wFL1C genes, we decided to screen E. faecalis JH2-2 for the wFL1C prophage. wFL1C (ORFs 40-44)-specific primers (Table 2) were used in PCR with JH2-2 extracts, prepared as described previously. As seen in Fig. S4 , wFL1C-specific amplicons were generated from the JH2-2 templates and the wFL1C-specific primers, confirming the presence of (at least a portion of) a wFL1C prophage in the JH2-2 chromosome. PCR, using JH2-2 template DNA and primers specific for regions of the wFL1C genome other than ORFs 40-44, failed to produce any amplicons (data not shown).
Deletion of the lysogeny module and replacement of cro promoter in wEf11(D61-1, wFL1C40-44) by allelic exchange
Although the wEf11(D61-1, wFL1C40-44) recombinant exhibited enhanced lytic activity (compared with wild-type virus) as judged by the extensively enlarged plaques it forms in lawns of host cells (Fig. 2) , and the elevated titres it achieved in productive infection (Fig. 3) , these variants of phage wEf11 would still be expected to be subject to repression due to superinfection immunity, and be limited in lytic infection due to the possibility of entering into lysogeny, rather than generating a productive infection. Consequently, we sought to delete all lysogeny-related genes and render regulatory genetic elements insensitive to repressor control. , erm, nisR/K, D61-1, wFL1C40-44)] lysogens produced large, clear plaques (Fig.  2) , and was designated wEf11(vir) PnisA . As shown below, this derivative of temperate phage wEf11 had all the characteristics of a virulent virus.
Isolation of cured E. faecalis TUSoD11
After electroporation of E. faecalis TUSoD11 with the gene exchange vector pD31-36 PnisA, erythromycin-resistant colonies were screened by PCR for deletion of ORFs 31-36. Unexpectedly, a few colonies were found with deletions of not only the intended ORF 31-ORF 36 lysogeny module, but also all other phage genes outside this region. These clones may have been generated by the homologous recombination between the gene exchange vector and a permutated and terminally redundant prophage DNA that may have positioned the ORF 30 and ORF 37 regions at either end of the wEf11 prophage within the host E. faecalis TUSoD11 chromosome. These E. faecalis clones, lacking any detectable wEf11 genes, were designated TUSoD11 (DwEf11), and were further tested for phage induction. No phage could be induced from these cells. Virulence-associated alterations in phage wEf11 genome Restoration of adsorption of wEf11 and wEf11(D61-1, wFL1C40-44) by a cured E. faecalis strain Although it is not surprising that neither wEf11 nor wEf11(D61-1, wFL1C40-44) could produce a viable infection on the lysogenic TUSoD11 strain due to superinfection immunity, it was interesting that incubation of either wEf11 or wEf11(D61-1, wFL1C40-44) with a cell suspension of lysogenic E. faecalis strain TUSoD11 failed to result in phage adsorption to the cells. In contrast, cell suspensions of either strain JH2-2 (non-lysogenic with respect to wEf11) or TUSoD11(DwEf11), a cured E. faecalis strain, effectively adsorbed both virus strains (Table 3) .
Host range of wEf11(vir)

PnisA
The ability of wEf11 (vir) PnisA , in comparison with wt wEf11, to generate a productive infection in strains of E. faecalis is shown in Table 4 . Whereas wild-type wEf11 productively infected only four (6 %) of the 67 E. faecalis strains tested, productive infection occurred in 33 (49 %) of these strains inoculated with phage wEf11(vir)
PnisA . The panel of E. faecalis strains was also screened by PCR for the presence of a prophage, using wEf11-specific primers. Among the strains tested, 14 were found to be wEf11 lysogens (data not shown). Of these 14 wEf11 lysogens, none was susceptible to wild-type wEf11, although four of these lysogenic strains (strains GS2, GS8, GS22 and GS25) could be productively infected by wEf11 (vir) PnisA . Furthermore, the presence of the wEf11 repressor gene (cI, ORF 36) was confirmed in these wEf11 (vir) PnisA -susceptible lysogenic strains by PCR (data not shown).
DISCUSSION
The outcome between the competing, alternative life cycles of lysogeny and productive infection in temperate bacterial viruses is largely determined by the presence or absence of functional early expression genes, such as those coding for the repressor and the integrase proteins, and the related early gene promoters (Ptashne, 2004) . In the case of bacteriophage wEf11, a genomic module of six contiguous putative early expression genes with lysogeny-related functions was identified by sequencing and homology comparison with known lysogeny-related genes of other bacterial viruses (Stevens et al., 2011) . In the same study, a region of the wEf11 genome with marked similarity to the Fig. 3 . One-step growth curve for phages wEf11 (wild-type), wEf11(D61-1, wFL1C40-44) (spontaneous recombinant) and wEf11(vir)
PnisA (virulent variant) . Exponential phase broth cultures of E. faecalis JH2-2 were infected with a phage stock. After adsorption for 30 min, the cells were collected by centrifugation, washed and incubated at 37 6C. At various time points aliquots of the suspension were centrifuged to remove the cells, and the supernatants were plaque assayed for phage titre using JH2-2 indicator cells. ($) wEf11 titre (p.f.u. ml P R and P L early promoter region of the temperate lactococcal bacteriophage TP901-1 (Madsen & Hammer, 1998) was also detected, suggesting a similar regulatory function in wEf11. To confirm the predicted functions of these regions of the wEf11 genome, and to develop a potentially useful agent for phage therapy, we wished to determine whether deletion or replacement of these sites in phage wEf11 would result in a derivative virus with virulent rather than temperate properties. There is substantial precedent for temperate to virulent conversion of phage by modification of these genomic sites (Bailone & Devoret, 1978; Flashman, 1978; Donnelly-Wu et al., 1993; Bruttin & Brüssow, 1996; Ford et al., 1998) .
Our previous analysis of the phage wEf11 genome concluded that a module of six contiguous genes (ORFs 31-36) was responsible for functions related to the establishment of lysogeny (Stevens et al., 2011) . This module included a putative integrase (ORF 31) and a putative cI repressor (ORF 36). In the present investigation, we found that these six genes are completely dispensable for lytic cycle function, as deletion of these genes did not prevent productive infection by the virus. Infection of lawns of host cells by the mutant virus lacking these genes produced clear plaques. Furthermore, we were unable to recover surviving (presumptive lysogenic) cells from the plaques produced by the mutant virus lacking ORFs 31-36. Therefore, these data suggest that the predicted lysogenyrelated functions of these genes were correct, and that by deleting these genes from the viral genome, we have generated a wEf11 mutant that is incapable of lysogeny. It should be noted, however, that complementation studies to confirm the function of these (putative lysogeny-related) genes could not be carried out because the wEf11(vir)
PnisA genome includes a nisin promoter, in place of the wild-type cro promoter, which is not sensitive to repression by the cI gene product (see below).
Similarly, we previously identified a stem-loop structure surrounded by P L and P R promoter sequences in the wEf11 genome lying between a putative cI repressor gene and a putative cro gene, which was highly similar to the P R /P L promoter/operator region of Lactococcus bacteriophage TP901-1 (Stevens et al., 2011; Madsen & Hammer 1998 ORFs 31-36 as well as the cro promoter were allelically exchanged for the nisin promoter cassette, and ORFs 61-1 were allelically exchanged with gp40-gp44 of wFL1C. Primer binding sites are indicated by and . Therefore, these data support our computationally based prediction that this region of the wEf11 genome (i.e. between ORFs 36 and 37) is a regulatory sequence that determines the outcome of phage infection between lysogeny and a productive infective cycle. Thus, it appears that the wEf11(vir) pnisA variant resulting from replacing the wild-type P R /P L promoter/operator sequence with a nisininducible promoter, P nisA , is indeed insensitive to cI repression. Surprisingly, spontaneous recombinational replacement of five genes (ORFs 61-65) of the DNA replication/modification module and one gene (ORF 1/terminase A) of the packaging module by five genes (ORFs 40-44) of E. faecalis phage wFL1C also had an effect on the virulence properties of the virus. While this genetic recombination had no effect upon host range, it did markedly alter the lytic properties observed during infection of either broth cultures or soft agar overlay lawns of susceptible host cells. Broth cultures rapidly and more thoroughly cleared, after infection by the recombinant phage wEf11(D61-1, wFL1C40-44), as compared with infection by the wild-type wEf11 virus. Similarly, plaques produced by the recombinant phage wEf11(D61-1, wFL1C40-44) appeared as large, extensively spreading lytic zones with a clearer centre, compared with those formed by the wild-type wEf11 virus. As the predicted function of the replaced genes involved either DNA replication/modification (ORFs 61-65), or packaging (ORF 1), we hypothesize that the replacement (wFL1C) genes contributed to a more robust, more productive lytic infection by increasing the efficiency of either phage DNA synthesis or packaging, or both.
The results of one-step growth experiments for wild-type wEf11 and recombinant wEf11(D61-1, wFL1C40-44) phages appear to bear out the above hypothesis that recombination of wEf11 with the wFL1C genes results in a greatly (.100-fold) enhanced production of progeny virus (Fig. 3) . As both the wild-type (wEf11) and the recombinant wEf11(D61-1, wFL1C40-44) phages are temperate, and we do not know what proportion of infected cells undergoes productive infection and what proportion becomes lysogens, we cannot accurately determine a burst size for either strain (although the latent period of both strains, approx. 30 min, appears to be similar). That is, it is not possible to determine from these data whether the difference in titre observed between the two phage strains is due to a greater burst size produced by the recombinant or a higher proportion of cells in the population that undergoes lytic infection (or both). Nevertheless, these data do demonstrate that a much greater titre of virus is produced in E. faecalis populations infected by the wEf11(D61-1, wFL1C40-44) recombinant as compared with the wild-type virus.
In addition, the source of the wFL1C genes (i.e., the E. faecalis JH2-2 chromosome) was unexpected, as previous studies reported that this E. faecalis strain was susceptible to wFL1C infection, and in fact could form wFL1C lysogens following wFL1C infection, suggesting that this strain did not initially harbour a wFL1C prophage (Yasmin et al., 2010) . This conundrum was solved when we used PCR to attempt to detect other regions of the wFL1C genome in JH2-2. No other regions of the wFL1C genome could be detected in JH2-2, suggesting that the wFL1C sequence that we detected was part of a defective (incomplete) prophage, or was the only wFL1C-like portion of a complete prophage. Under such circumstances, it would not be surprising for JH2-2 cells (lacking the wFL1C immunity functions) to be susceptible to wFL1C infection, while being the source of a limited number of wFL1C genes.
The lack of adsorption of either the wild-type or the spontaneous recombinant phage wEf11(D61-1, wFL1C40-44) by lysogenic E. faecalis strain TUSoD11 suggests either that this lysogen lacked the phage receptor, or that the phage receptor had been modified, rendering it incapable of binding the phage ligand. The fact that curing TUSoD11 rendered it capable of adsorbing wEf11 supports the notion that lysogeny either altered or eliminated the phage receptor on the cell surface. Prophage-mediated modification of phage receptors has been long known and well documented for several other phage/host systems (Uetake et al., 1958; Holloway & Cooper, 1962; Losick & Robbins, 1967; Castillo & Bartell, 1974; Gemski et al., 1975; Kuzio & Kropinski, 1983; Tomás & Kay, 1984) . Enzymes specified by these phages catalyse modifications of phage receptor sites (e.g. O-acetylation of the lipopolysaccharide side chains, changes in the bonding between the lipopolysaccharide trisaccharide units from a1A4 to b1A4) on the host cell, resulting in the inability of the cell to adsorb additional phage. Although the previous examples of phage receptor modification involve Gram-negative bacteria, it is possible that a similar phenomenon may occur in E. faecalis as the phage receptors in most Gram-positive, low G+C bacteria are cell surface polysaccharides (Vidaver & Brock, 1966; Douglas & Wolin, 1971; Cleary et al., 1977; Yokokura 1977; Keogh & Pettingill, 1983; Valyasevi et al., 1990; Schäfer et al., 1991) . If this is the case, then evolutionarily speaking, it may be that originally E. faecalis TUSoD11 was nonlysogenic and possessed cell-surface phage receptors. Upon infection and lysogenization by a temperate phage wEf11 at some time in the past, the cell's phage receptors were lost or modified, resulting in a non-phage-adsorbable cell surface. However, once cured of the phage, the cell surface changed back to its original form that could again adsorb the phage and support virus infection. However, note that we found some lysogenic E. faecalis strains to be sensitive to
wEf11(vir)
PnisA , indicating that they must be able to adsorb the virus. Why some lysogens (e.g. E. faecalis GS8) should be able to adsorb the phage while others (e.g. TUSoD11) do not remains to be determined.
In summary, we have developed a virulent variant of temperate E. faecalis phage wEf11 that is incapable of lysogeny, is insensitive to cI repression, is highly lytic and has a greatly extended host range compared with the wildtype virus. In the course of constructing this virus we have increased our understanding of the genome of phage wEf11 by confirming the predicted function of several of the genomic loci. These include regions responsible for establishing and maintaining lysogeny. In addition, we have determined that incorporating allelic alternatives in a region of the genome responsible for DNA replication/ modification and packaging results in enhancement of productive infection in the host cell population, thereby capturing phage mozaicism happening in real-time.
We recognize that further genetic modifications will be necessary to develop a phage that may be clinically useful in managing enterococcal infections. Replacing the repressorsensitive cro promoter with the repressor-insensitive, nisininducible promoter system to drive phage lytic infection functions proved to be a very effective and useful strategy in making genetic modifications in the virus. However, because the inducing agent, nisin, is a toxic protein, this approach would not be suitable in an agent designed for therapeutic application. Consequently, we are exploring alternative, constitutive promoters to replace the nisin-inducible promoter in variants of the wEf11(vir)
PnisA strain. Similarly, we used antibiotic (erythromycin) resistance to select transformant lysogen clones containing prophages with the desired genotype. It would be necessary to delete this determinant prior to using this agent clinically. Finally, while the virulent variant phage that we have constructed possesses an eminently greater host range than the wild-type virus, there are still E. faecalis strains that do not appear to be sensitive to this virus. We are exploring additional strategies aimed at further expanding the host range of the
PnisA virulent variant that we have constructed.
